Profile_bird

Hey there! Novartis is using Twitter.

Twitter is a free service that lets you keep in touch with people through the exchange of quick, frequent answers to one simple question: What's happening? Join today to start receiving Novartis's tweets.

Already using Twitter
from your phone? Click here.

Novartis

  1. Watch "Fighting Malaria in Tanzania": Getting meds to malaria patients via grassroots education and more http://bit.ly/26U9Rh 2:48 AM Nov 20th from Seesmic
  2. We're honored: Scrip names our Executive Committee the Management Team of the Year. http://bit.ly/9ExCr 5:30 AM Nov 19th from web
  3. We're pleased: Scrip recognizes our collaboration with Lonza as Best Partnership Alliance. http://bit.ly/9ExCr 5:30 AM Nov 19th from web
  4. (US only) Frequent heartburn treatment is here: Novartis launches over-the-counter Prevacid®24HR. http://bit.ly/gGIet 11:29 PM Nov 11th from web
  5. @VinumVine Apologies for the delay in responding. Thanks for your understanding 7:39 AM Nov 7th from Seesmic in reply to VinumVine
  6. @VinumVine Thx for your Q. For H1N1 vac., Novartis on track for US delivery http://bit.ly/3qg86P Seasonal flu delivered http://bit.ly/3EtGp4 7:38 AM Nov 7th from Seesmic in reply to VinumVine
  7. Celtura approval is key step toward replacing 50 year-old egg-based flu vaccine production w/ modern biotechnology http://bit.ly/2SHynD 1:00 AM Nov 5th from Seesmic
  8. Clinical trials in more than 1850 individuals across all age groups show strong efficacy for Celtura http://bit.ly/2SHynD 11:54 PM Nov 4th from Seesmic
  9. Novartis receives German regulatory approval for Celtura®, 1st adjuvanted cell culture-based A(H1N1) flu vaccine http://bit.ly/2SHynD 10:34 PM Nov 4th from Seesmic
  10. Novartis opens $250M advanced technical R&D & manuf. facility in Changshu, furthering economic dev. of Jiangsu province http://bit.ly/2xz5rH 12:38 PM Nov 3rd from web
  11. Novartis Institute of BioMedical Research in Shanghai to research new meds to treat highly prevalent diseases in China http://bit.ly/2xz5rH 7:19 AM Nov 3rd from Seesmic
  12. Novartis to invest $1Bio to build largest pharmaceutical R&D institute in China http://bit.ly/2xz5rH 6:47 AM Nov 3rd from Seesmic
  13. Novartis is proud to be ranked one of the top 50 "world's most attractive employers." http://bit.ly/wBCkA 8:41 AM Oct 30th from web
  14. New Novartis biological therapy approved in EU to treat patients with CAPS, a rare auto-inflammatory disease http://bit.ly/3rl3EN 11:42 PM Oct 27th from mobile web
  15. Novartis thanks the readers of MedAdNews for naming us "most admired pharmaceutical company" http://bit.ly/6BSDH 9:21 AM Oct 23rd from web
  16. Novartis receives approval in EU for new 3-in-1 once-daily single pill to treat patients with high blood pressure http://bit.ly/2TLyTf 10:32 PM Oct 22nd from web
  17. Q3 Analyst webcast (slides/audio) starting now. Follow it here: http://bit.ly/1yt33p 5:02 AM Oct 22nd from web
  18. Novartis delivers strong new product momentum and operational performance in first 9 mos. of 2009 http://bit.ly/2Dlbp6 10:13 PM Oct 21st from web
  19. We will announce our Q3 results tomorrow, Oct 22. Analyst webcast starts 2pm CET. More to come here http://bit.ly/1yt33p 7:07 AM Oct 21st from web
  20. New Novartis Phase II study results announced for treatment of patients with chronic gout http://bit.ly/1utmwZ 4:58 AM Oct 20th from Seesmic
  • Name Novartis
  • Location Switzerland
  • Web http://novartis.com
  • Bio Latest Novartis news and updates from Novartis Communications
10 Following 3,617 Followers 101 Listed
Sandoz Brasil CDC Flu Pandemic Flu BirdFluGov Bird Flu/Swine Flu Health Dr. Sanjay Gupta BBC Health CDC Emergency WHO News